ipilimumab
bms
['yervoy', 'ipilimumab', 'bms']
...#til now! enter the first ph. 3 randomized controlled trial comparing til to one such therapy, bms's yervoy (ipilimumab). patients lived double the time w/o their cancer progressing on til than with the immunotherapy drug. presented sat. at #esmo22 by 
Health & science journalist?Biopharma reporter @PrecOncNews @GenomeWeb?@ColumbiaJourn alum?I cover cancer treatment??, genomics??, + sometimes ??s?DM for signal